Cancer Research AACR Conference on Molecular Diagnostics - 2008  AACR Conference on Molecular Diagnostics - 2008
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 30, 658-664, March 1, 1970]
© 1970 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Clifton, K. H.
Right arrow Articles by Yatvin, M. B.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Clifton, K. H.
Right arrow Articles by Yatvin, M. B.

Cell Population Growth and Cell Loss in the MTG-B Mouse Mammary Carcinoma1

Kelly H. Clifton2 and Milton B. Yatvin3

Radiobiology Laboratories, Departments of Radiology and Pathology, University of Wisconsin Medical School, Madison, Wisconsin 53706

Two radiobiochemical methods were used in studies of tumor cell population growth rate and cell loss during growth of grafts of C3H mouse mammary carcinoma MTG-B in BC3F1 mice. Six-hr uptake of orotic acid-5-3H into DNA and RNA was highest in small tumors (25 mg, Day 5 after grafting). RNA uptake fell to one-third maximum by Day 7 and DNA reached that point by Day 9, thereafter remaining constant until Day 16 (1200-mg tumors). Tumor DNA was prelabeled with multiple injections of either tritiated thymidine or 5-iodo-2'-deoxyuridine-125I given prior to the first day of sacrifice. The specific activity of tritiated thymidine-labeled DNA fell exponentially from Days 5 through 10 and then tended to plateau. 5-Iodo-2'-deoxyuridine-125I-labeled DNA specific activity decreased similarly until Day 13, and slowed thereafter. In all experiments, the growth rate of "cleaned" viable tumor tissue decreased as tumors became larger. It is postulated that: (a) the rate of decrease in 125I-labeled tumor DNA specific activity is the negative of the "potential" cell population growth rate exclusive of cell death; (b) the potential rate of cell population growth is constant in tumors weighing 22 to 1200 mg or more; (c) cell death rate disproportionately increases in large tumors; and (d) tritiated thymidine released from dying cells is reutilized more efficiently than 5-iodo-2'-deoxyuridine-125I. These data are consistent with the postulate that increased cell death and decreased nucleic acid synthetic activity result from the known decrease in functional vascular space relative to tumor size. Evidence for the constancy in rate of cell population increase during tumor latency is also presented.

1 Project supported in part by American Cancer Society Grant T661 and National Cancer Institute Grant CA-08318.

2 Supported in part from Radiotherapy Center Grant Ca-06295, National Cancer Institute, USPHS.

3 Research Career Development Awardee CA-38655.

Received 1/15/69. Accepted 8/ 1/69.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1970 by the American Association for Cancer Research.